Abstract | OBJECTIVE: To compare the predictive ability for oncologic outcomes among current tumor size cut-points and clinically relevant alternatives to determine which are optimal. METHODS: Patients who underwent radical or partial nephrectomy between 1970 and 2010 for T1-2Nx/N0M0 renal cell carcinoma (RCC) were identified. Associations between tumor size and progression-free survival (PFS) and cancer-specific survival (CSS) were evaluated using Kaplan-Meier analyses and Cox models. Predictive ability was assessed using c-indexes. RESULTS: The cohort included 3304 patients with a median age of 63 years (interquartile range 53, 70). Median follow-up among survivors was 9.9 years (interquartile range 6.9, 14.3). There were 536 patients who progressed and 354 who died from RCC. For RCC tumors ≤3.0 cm, 10-year PFS and CSS rates were 93%-95% and 97%-99%, respectively. For tumors >3.0-4.0 cm, PFS and CSS began to decline (91% and 95%, respectively), with further gradual declines in PFS and CSS with increasing tumor size. Plots of hazard ratios for progression and RCC death as a function of tumor size did not reveal major inflection points. Differences in discrimination based on various combinations of tumor-size cut-points for progression or RCC death were small, with c-indexes ranging between 0.691-0.704 and 0.734-0.750, respectively. CONCLUSION: RCC tumors ≤3.0 cm in size are associated with favorable outcomes. Thereafter, risks of progression and RCC death increase gradually with tumor size, with no compelling biological reason to endorse a given cut-point over another.
|
Authors | Bimal Bhindi, Christine M Lohse, Ross J Mason, Mary E Westerman, John C Cheville, Matthew K Tollefson, Stephen A Boorjian, R Houston Thompson, Bradley C Leibovich |
Journal | Urology
(Urology)
Vol. 109
Pg. 121-126
(Nov 2017)
ISSN: 1527-9995 [Electronic] United States |
PMID | 28412331
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2017 Elsevier Inc. All rights reserved. |
Topics |
- Aged
- Carcinoma, Renal Cell
(pathology, surgery)
- Female
- Humans
- Kidney Neoplasms
(pathology, surgery)
- Male
- Middle Aged
- Neoplasm Staging
- Nephrectomy
- Predictive Value of Tests
- Prognosis
- Tumor Burden
|